BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35077495)

  • 1. Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination.
    Ramatillah DL; Gan SH; Pratiwy I; Syed Sulaiman SA; Jaber AAS; Jusnita N; Lukas S; Abu Bakar U
    PLoS One; 2022; 17(1):e0262438. PubMed ID: 35077495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome.
    Ali S; Khalid S; Afridi M; Akhtar S; Khader YS; Akhtar H
    JMIR Public Health Surveill; 2021 May; 7(5):e27609. PubMed ID: 34009133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.
    Suresh K; Figart M; Formeck S; Mehmood T; Abdel Salam M; Bassilly D
    J Investig Med High Impact Case Rep; 2021; 9():23247096211019557. PubMed ID: 34105382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective evaluation of COVID-19 patients treated with Tocilizumab: who should be treated?
    Çelik Ekinci S; Akkaya Işık S
    J Infect Dev Ctries; 2021 Dec; 15(12):1825-1832. PubMed ID: 35044939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
    Gonzales-Zamora JA; Quiroz T; Vega AD
    Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Memon D; Kodre A; Potdar P; Mane M; Borse R; Pawar V; Patil D; Banerjee D; Bhoite K; Pharande R; Kalyani S; Raut P; Bapte M; Mehta A; Reddy MS; Bhayani K; Laxmi SS; Vishnu PD; Srivastava S; Khandelwal S; More S; Shinde R; Pawar M; Harshe A; Kadam S; Mahajan U; Joshi G; Mane D
    Medicine (Baltimore); 2021 Jul; 100(29):e26705. PubMed ID: 34398044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients.
    Demir Önder K; Seremet Keskin A; Berk H; Seyman D; Öztoprak N
    Turk J Med Sci; 2021 Dec; 51(6):2835-2849. PubMed ID: 34418000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region.
    Eleni M; Evangelia M; Eleftheria K; Vasilios V; Vana S; Vissaria S; Evangelos B; Ioannis K
    Pathog Glob Health; 2021 Jun; 115(4):243-249. PubMed ID: 33645468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
    Herth FJF; Sakoulas G; Haddad F
    Respiration; 2020; 99(12):1145-1153. PubMed ID: 33316806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients.
    Sarhan RM; Harb HS; Abou Warda AE; Salem-Bekhit MM; Shakeel F; Alzahrani SA; Madney YM; Boshra MS
    J Infect Public Health; 2022 Jan; 15(1):116-122. PubMed ID: 34764044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.
    Gokhale Y; Mehta R; Kulkarni U; Karnik N; Gokhale S; Sundar U; Chavan S; Kor A; Thakur S; Trivedi T; Kumar N; Baveja S; Wadal A; Kolte S; Deolankar A; Pednekar S; Kalekar L; Padiyar R; Londhe C; Darole P; Pol S; Gokhe SB; Padwal N; Pandey D; Yadav D; Joshi A; Badgujar H; Trivedi M; Shah P; Bhavsar P
    BMC Infect Dis; 2021 Mar; 21(1):241. PubMed ID: 33673818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tocilizumab therapy in critically ill patients with severe acute respiratory syndrome coronavirus 2.
    Saffo Z; Guo W; Springer K; Maksimowicz-McKinnon K; Kak V; McKinnon JE; Bhargava P
    J Osteopath Med; 2021 Jul; 121(8):705-714. PubMed ID: 34237804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review on sarilumab in COVID-19.
    Khiali S; Rezagholizadeh A; Entezari-Maleki T
    Expert Opin Biol Ther; 2021 May; 21(5):615-626. PubMed ID: 33161757
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
    Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
    PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab.
    Morrison AR; Johnson JM; Griebe KM; Jones MC; Stine JJ; Hencken LN; To L; Bianchini ML; Vahia AT; Swiderek J; Ramesh MS; Peters MA; Smith ZR
    J Autoimmun; 2020 Nov; 114():102512. PubMed ID: 32646770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
    Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE
    Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.